REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuroxtimular S.A.S. Ips (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Ambulatory Health Care Services
Full name: Neuroxtimular S.A.S. Ips Profile Updated: March 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Neuroxtimular S.A.S. Ips is an enterprise in Colombia, with the main office in Barranquilla. The enterprise currently operates in the Ambulatory Health Care Services sector. It was established on February 17, 2010. 11 - 50 (2025) employees currently work for Neuroxtimular S.A.S. Ips. The company’s latest financial report indicates a net sales revenue drop of 23.27% in 2025. Its total assets grew by 5.93% over the same period. The net profit margin of Neuroxtimular S.A.S. Ips decreased by 1.03% in 2025.

Headquarters
Cr 43B 85 81
Barranquilla; Atlantico;

Contact Details: Purchase the Neuroxtimular S.A.S. Ips report to view the information.

Basic Information
Total Employees:
Purchase the Neuroxtimular S.A.S. Ips report to view the information.
Registered Capital:
Purchase the Neuroxtimular S.A.S. Ips report to view the information.
Financial Auditors:
Purchase the Neuroxtimular S.A.S. Ips report to view the information.
Incorporation Date:
February 17, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Neuroxtimular S.A.S. Ips report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-23.27%
Total Operating Revenue
-23.27%
Operating Profit
-52.88%
EBITDA
-47.52%
Net Profit/Loss for the Period
-27.17%
Total Assets
5.93%
Total Equity
7.38%
Operating Profit Margin
-7.85%
Net Profit Margin
-1.03%
Return on Equity (ROE)
-4.2%
Quick Ratio
0.94%
Cash Ratio
-0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?